First Mercantile Trust Co buys $932,344 stake in Amsurg Corp (AMSG)

Amsurg Corp (AMSG) : First Mercantile Trust Co scooped up 6,361 additional shares in Amsurg Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 7, 2016. The investment management firm now holds a total of 14,120 shares of Amsurg Corp which is valued at $932,344.Amsurg Corp makes up approximately 0.13% of First Mercantile Trust Co’s portfolio.

Other Hedge Funds, Including , Simplex Trading added AMSG to its portfolio by purchasing 3,364 company shares during the most recent quarter which is valued at $222,125. Amsurg Corp makes up approx 0.03% of Simplex Trading’s portfolio. New England Research Management added AMSG to its portfolio by purchasing 4,800 company shares during the most recent quarter which is valued at $321,456. Amsurg Corp makes up approx 0.27% of New England Research Management’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in AMSG by selling 33,758 shares or 15.89% in the most recent quarter. The Hedge Fund company now holds 178,692 shares of AMSG which is valued at $11,967,003. Amsurg Corp makes up approx 0.05% of Bnp Paribas Arbitrage Sa’s portfolio.Independent Portfolio Consultants boosted its stake in AMSG in the latest quarter, The investment management firm added 20,155 additional shares and now holds a total of 21,315 shares of Amsurg Corp which is valued at $1,427,466. Amsurg Corp makes up approx 0.45% of Independent Portfolio Consultants’s portfolio. Eqis Capital Management added AMSG to its portfolio by purchasing 4,946 company shares during the most recent quarter which is valued at $331,234. Amsurg Corp makes up approx 0.02% of Eqis Capital Management’s portfolio.

Amsurg Corp closed down -0.48 points or -0.72% at $66.03 with 9,94,485 shares getting traded on Friday. Post opening the session at $66.85, the shares hit an intraday low of $65.01 and an intraday high of $67.07 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Amsurg Corp reported $1.10 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.08. The company had revenue of $859.80 million for the quarter, compared to analysts expectations of $769.68 million. The company’s revenue was up 21.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 EPS.

Many Wall Street Analysts have commented on Amsurg Corp. Amsurg Corp was Initiated by Citigroup to “Buy” on Sep 26, 2016.

AmSurg Corp. is the owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology children’s services emergency medicine and radiology. The Company operates in two segments: ambulatory surgery services and outsourced physician services. The ambulatory services segment which acquires develops and operates ambulatory surgery centers in partnership with physicians. The physician services segment which provides outsourced physician services in multiple specialties to hospitals ambulatory surgery centers and other healthcare facilities primarily in the areas of anesthesiology children’s services emergency medicine and radiology. It operated approximately 246 ASCs in over 34 states and the District of Columbia in partnership with approximately 2000 physicians and provided physician services to over 320 healthcare facilities in 24 states.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Amsurg Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amsurg Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.